KV
Kairos Ventures
Venture CapitalActiveKairos Ventures invests in ideas, patents, and businesses from the top universities and scientists.
44
Investments
3
Exits
$500M
AUM
6.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Kairos Ventures.
Investment Thesis & Strategy
Kairos Ventures invests in early-stage companies, including ideas and patents, originating from top universities and scientists across various sectors. They focus on backing innovative technologies and research with high growth potential.
Investment Activity
Deals per year over the last 5 years
2
20191
20208
20210
20221
2023Portfolio Companies
Selected investments from their portfolio of 44 companies
V
VentureWell
Other · Growth, 2023
C
Cellino
Biotech · Series A, 2021
T
Tessera Therapeutics
Biotech · Series A, 2021
K
Kytopen
Biotech · Series A, 2021
E
Epirium Bio
Biotech · Series A, 2021
X
Xilis
Biotech · Series A, 2021
E
Enveda Biosciences
Biotech · Series A, 2021
E
E-Therapeutics
Biotech · Series A, 2021
R
ReNetX Bio
Biotech · Series A, 2021
A
Aegle Therapeutics
Biotech · Series A, 2020
L
Locus Biosciences
Biotech · Series A, 2019
S
Sana Biotechnology
Biotech · Series A, 2019
Notable Exits
CompanyTypeYearValue / Acquirer
LimeAcquisition2024—
BirdIPO2021$2.3B
LyftIPO2019$24.3B
Frequently Asked Questions
Kairos Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Group 11
Beverly Hills, United States · 68 deals
Third Wave Digital
Beverly Hills, United States · 59 deals
Baroda Ventures
Beverly Hills, United States · 51 deals
WndrCo
Beverly Hills, United States · 31 deals
Bracket Capital
Beverly Hills, United States · 28 deals
Blue Bear Capital
Beverly Hills, United States · 22 deals